Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Transcatheter Aortic Valves At The Five-Year Mark

Executive Summary

Published data on transcatheter aortic valve implantation has reached the five-year mark and the outcomes suggest these devices may be as durable as many surgical valves, which is good news for this rapidly-growing market.

You may also be interested in...



Transcatheter Valves At The Tipping Point

Although Edwards is the pioneer and market leader in TAVR, there is no shortage of competitors – in both the aortic and mitral valve segments – developing next-generation devices who would be happy with a fraction of this potential multibillion-dollar opportunity.

CMS To Pay Co-Surgeons For Transcatheter Valve Procedures, But At Lower Value Than Sought By Physicians

Surgeons and cardiologists who perform transcatheter aortic valve replacement procedures will be paid for the total amount of their work in 2013, but CMS’ adoption of a lower relative value unit for TAVR will result in a lower payment amount.

Transcatheter Valve Procedures Expected, Spurring Growth In Hybrid Operating Rooms

Infrastructure requirements for hospitals looking to expand their offerings to TAVR include a boatload of medical equipment. ECRI Institute discussed hospital considerations for offering transcatheter aortic valve implantation services in a recent webinar.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT035572

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel